🔎 Trials Near Me

Beranda › Glioma › Washington › Seattle

Uji klinis Glioma di Seattle, WA

11 studi untuk Glioma mencari peserta di lokasi sekitar Seattle (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Menerima pesertaFase 1/2
  • Seattle Children's Hospital, Seattle
12 Months – 21 Years · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05099003

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Menerima pesertaFase 2
  • Seattle Children's Hospital, Seattle
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06838676

Targeted Pediatric High-Grade Glioma Therapy

Menerima pesertaStudi observasional
  • Seattle Children's Hospital, Seattle
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Menerima pesertaFase 2
  • Seattle Children's Hospital, Seattle
Usia 12 hingga 39 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Menerima pesertaFase 3
  • Fred Hutch Cancer Center, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Menerima pesertaFase 2
  • Seattle Children's Hospital, Seattle
Usia 3 hingga 39 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05096481

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Menerima pesertaFase 2
  • University of Washington School of Medicine, Seattle
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05503797

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Menerima pesertaFase awal 1Sukarelawan sehat diterima
  • Seattle Children's Hospital, Seattle
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Menerima pesertaFase 2
  • Seattle Children's Hospital, Seattle
12 Months – 39 Years · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT05843253

Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors

Menerima pesertaFase 1
  • Seattle Children's Hospital, Seattle
Usia 1 hingga 26 · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT04185038

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Menerima pesertaFase awal 1
  • Seattle Children's Hospital, Seattle
Hingga usia 21 · Semua jenis kelamin · Diperbarui 18 Mar 2026 · NCT04655404

Uji klinis Glioma di kota lain

Studi lain di Seattle

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.